However, the human bodys ability to absorb B12 orally is limited
BPC-157 (Body Protective Compound-157) Research Soft Tissue Healing Consistent Positive Results Across All Models (PubMed, 2019) A critical review published in Cell and Tissue Research examined BPC-157s published evidence across musculoskeletal soft tissue healing specifically tendon, ligament, and skeletal muscle injury models
Potential Benefits Soft-tissue repair (preclinical): Animal data on BPC-157 and TB-500 describes faster tendon, ligament and muscle repair via angiogenesis and cell migration
These injections are given to pets, farm animals, and other animals to help them stay healthy and grow properly
These symptoms typically resolve within 24 hours.* Not for Everyone: This therapy is not recommended for individuals allergic to cobalamin (B12), those with liver disease, or those currently taking medications that interact with methyl donors
Besides the acute phase gastrointestinal effects which may lead to up to 10% of people discontinuing the drugs, there are other potential GI side effects of obstruction, excessive loss of muscle mass, and potentially association with some eye disease adverse events